MODDERN Cures Act of 2013
Latest action · Jan 9, 2014 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 17, 2013
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2013 or MODDERN Cures Act of 2013 - Requires the Secretary of Health and Human Services (HHS) to: (1) establish the Advanced Diagnostics Education Council to recommend standard terms and definitions related to innovative diagnostics for use by patients, physicians, health care providers, payers, and policy makers; and (2) publish a guide regarding such terms and definitions.
Sets forth additional factors for the Secretary to consider in determining the payment amount for new clinical diagnostic laboratory tests under gap filling procedures which are used when no comparable existing test is available.
Extends the exclusivity period for a medicine if the diagnostic test related to such drug has been determined by the Secretary to have been developed by, or with the participation of, the manufacturer or sponsor of the medicine, and use of the diagnostic tests provides for or improves: (1) the identification of a patient population for the medicine; or (2) the determination of the most appropriate treatment option for a patient population with the medicine.
Establishes a dormant therapy designation for medicine that addresses unmet medical needs. Gives such medicine 15 years of data exclusivity under which no drug can be approved by relying on the approval or licensure of the dormant therapy.
Directs the Secretary to arrange with the Institute of Medicine (or, if it declines, another appropriate entity) to study intellectual property laws and their impact on therapy and diagnostic development in order to formulate recommendations on how to facilitate the clinical evaluation and development of therapies currently available on the market for new potential indications.
Cosponsors 95
Members who signed on, in the order they did. Signatures ran from Sep 17, 2013 to Jan 2, 2015; 15 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-PA | Allyson Y. Schwartz | Original | Sep 17, 2013 |
| D-NM | Ben Ray Luján | Original | Sep 17, 2013 |
| R-MO | Billy Long | Original | Sep 17, 2013 |
| R-KY | Brett Guthrie | Original | Sep 17, 2013 |
| D-NY | Charles B. Rangel | Original | Sep 17, 2013 |
| D-IA | David Loebsack | Original | Sep 17, 2013 |
| R-MN | Erik Paulsen | Original | Sep 17, 2013 |
| R-OR | Greg Walden | Original | Sep 17, 2013 |
| R-NJ | Jon Runyan | Original | Sep 17, 2013 |
| D-MN | Keith Ellison | Original | Sep 17, 2013 |
| R-TX | Michael T. McCaul | Original | Sep 17, 2013 |
| R-OH | Patrick J. Tiberi | Original | Sep 17, 2013 |
| R-IL | Peter J. Roskam | Original | Sep 17, 2013 |
| R-NY | Peter T. King | Original | Sep 17, 2013 |
| R-NC | Walter B. Jones | Original | Sep 17, 2013 |
| R-FL | Ander Crenshaw | Sep 18, 2013 | |
| R-IN | Larry Bucshon | Sep 18, 2013 | |
| R-MN | Michele Bachmann | Sep 18, 2013 | |
| D-FL | Corrine Brown | Sep 30, 2013 | |
| R-IA | Tom Latham | Sep 30, 2013 | |
| D-FL | Theodore E. Deutch | Oct 8, 2013 | |
| D-IL | Bradley Scott Schneider | Oct 30, 2013 | |
| R-MI | Tim Walberg | Oct 30, 2013 | |
| R-IN | Todd Young | Nov 13, 2013 | |
| R-TX | Pete Sessions | Jan 29, 2014 | |
| D-WI | Gwen Moore | Feb 3, 2014 | |
| D-RI | James R. Langevin | Feb 3, 2014 | |
| D-IA | Bruce L. Braley | Feb 5, 2014 | |
| D-CA | Mark Takano | Feb 10, 2014 | |
| D-IN | André Carson | Feb 25, 2014 | |
| D-RI | David N. Cicilline | Feb 26, 2014 | |
| D-CA | Julia Brownley | Feb 27, 2014 | |
| R-PA | Jim Gerlach | Feb 28, 2014 | |
| D-MN | Betty McCollum | Mar 4, 2014 | |
| R-VA | Robert J. Wittman | Mar 6, 2014 | |
| R-CA | Dana Rohrabacher | Mar 12, 2014 | |
| D-CA | Jared Huffman | Mar 12, 2014 | |
| R-TN | John J. Duncan, Jr. | Mar 25, 2014 | |
| R-NC | Renee L. Ellmers | Mar 25, 2014 | |
| R-FL | Gus M. Bilirakis | Mar 26, 2014 | |
| R-WI | Reid J. Ribble | Apr 29, 2014 | |
| D-NY | Steve Israel | May 7, 2014 | |
| D-CA | Anna G. Eshoo | May 9, 2014 | |
| R-MO | Blaine Luetkemeyer | May 9, 2014 | |
| D-NH | Carol Shea-Porter | May 9, 2014 | |
| D-NY | Daniel B. Maffei | May 9, 2014 | |
| R-CA | Devin Nunes | May 20, 2014 | |
| D-VA | James P. Moran | May 20, 2014 | |
| D-GA | Sanford D. Bishop, Jr. | May 20, 2014 | |
| D-AZ | Ed Pastor | May 21, 2014 | |
| D-NC | G. K. Butterfield | May 22, 2014 | |
| R-AK | Don Young | May 28, 2014 | |
| D-OH | Joyce Beatty | May 28, 2014 | |
| D-NJ | Bill Pascrell, Jr. | May 30, 2014 | |
| D-NY | Paul Tonko | Jun 9, 2014 | |
| D-MN | Collin C. Peterson | Jun 17, 2014 | |
| D-NJ | Donald M. Payne, Jr. | Jun 23, 2014 | |
| R-NY | Michael G. Grimm | Jun 23, 2014 | |
| R-PA | Glenn Thompson | Jun 26, 2014 | |
| D-CA | Barbara Lee | Jul 9, 2014 | |
| R-PA | Michael G. Fitzpatrick | Jul 9, 2014 | |
| D-PA | Matt Cartwright | Jul 10, 2014 | |
| D-DC | Eleanor Holmes Norton | Jul 15, 2014 | |
| D-CA | Mike Thompson | Jul 17, 2014 | |
| R-FL | Ileana Ros-Lehtinen | Jul 31, 2014 | |
| D-CA | Scott H. Peters | Jul 31, 2014 | |
| R-MO | Ann Wagner | Sep 9, 2014 | |
| R-NC | George Holding | Sep 9, 2014 | |
| D-UT | Jim Matheson | Sep 9, 2014 | |
| D-FL | Joe Garcia | Sep 9, 2014 | |
| R-NE | Lee Terry | Sep 9, 2014 | |
| R-IL | Randy Hultgren | Sep 9, 2014 | |
| D-MN | Timothy J. Walz | Sep 9, 2014 | |
| R-FL | Vern Buchanan | Sep 9, 2014 | |
| D-OH | Tim Ryan | Sep 16, 2014 | |
| R-IN | Luke Messer | Sep 18, 2014 | |
| D-MA | Joseph P. Kennedy III | Nov 12, 2014 | |
| R-MN | John Kline | Nov 13, 2014 | |
| R-AZ | David Schweikert | Nov 18, 2014 | |
| D-FL | Alcee L. Hastings | Nov 20, 2014 | |
| R-SC | Joe Wilson | Dec 1, 2014 | |
| R-IN | Marlin A. Stutzman | Dec 2, 2014 | |
| R-MS | Steven M. Palazzo | Dec 2, 2014 | |
| R-IN | Jackie Walorski | Dec 3, 2014 | |
| D-MA | Michael E. Capuano | Dec 3, 2014 | |
| R-NJ | Rodney P. Frelinghuysen | Dec 3, 2014 | |
| D-MA | Richard E. Neal | Dec 8, 2014 | |
| R-TN | David P. Roe | Dec 10, 2014 | |
| R-NC | Howard Coble | Dec 10, 2014 | |
| D-MA | Katherine M. Clark | Dec 10, 2014 | |
| R-IN | Susan W. Brooks | Dec 10, 2014 | |
| D-MD | C. A. Dutch Ruppersberger | Dec 11, 2014 | |
| D-MO | Wm. Lacy Clay | Dec 11, 2014 | |
| R-MI | Dan Benishek | Dec 12, 2014 | |
| D-MA | Niki Tsongas | Jan 2, 2015 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 17, 2013 |
| Health Subcommittee | Referred Sep 20, 2013 | |
| House | Ways and Means Committee | Referred Sep 17, 2013 |
| House | Judiciary Committee | Referred Sep 17, 2013 |
| Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee | Referred Jan 9, 2014 |
Actions 4
Everything that happened, newest first.
- Jan 9, 2014Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
- Sep 20, 2013Referred to the Subcommittee on Health.
- Sep 17, 2013Introduced in House
- Sep 17, 2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H4480 | Glenn Thompson R-PA | May 20, 2014 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H5589.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 113-14 | CUTTING DHS DUPLICATION AND WASTEFUL SPENDING: IMPLEMENTING PRIVATE-SECTOR BEST PRACTICES AND WATCHDOG REC- OMMENDATIONS80 pages | Homeland Security Committee | Apr 26, 2013 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44032 | Patents and Regulatory Exclusivities: Issues in Pharmaceutical Innovation and Competition Archived | Report | May 1, 2015 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2085 | Diagnostic Innovation Testing and Knowledge Advancement Act of 2013 | Related bill | Jun 3, 2013 |
| HR 3091 | MODDERN Cures Act of 2013 | Related bill | Oct 15, 2013 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To promote the development of meaningful treatments for patients.
- Short Titles as Introduced
- MODDERN Cures Act of 2013
- Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2013
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Executive agency funding and structure
- Food and Drug Administration (FDA)
- Government studies and investigations
- Health
- Intellectual property
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Prescription drugs
Text 1
Each version as it was printed, newest first.
- Sep 17, 2013Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.